Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02117921|
Recruitment Status : Active, not recruiting
First Posted : April 21, 2014
Last Update Posted : July 15, 2020
|Condition or disease||Intervention/treatment||Phase|
|Chronic Pain||Behavioral: One-on-one interview and educational sessions. Reading material for educational series provided.||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain|
|Study Start Date :||February 2014|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2020|
|Experimental: MBS therapy education||
Behavioral: One-on-one interview and educational sessions. Reading material for educational series provided.
A one-on-one interview with the patient and the principal investigator and group educational sessions.
- Brief Pain Inventory Questionnaire [ Time Frame: 4 weeks ]To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.
- SF-12 Health Survey Scoring Demonstration [ Time Frame: 4 weeks ]
- SF-12 Health Survey Scoring Demonstration and Brief Pain Inventory Score [ Time Frame: 2 weeks, 4 weeks, 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02117921
|United States, Massachusetts|
|Beth Israel Deaconess Medical Center|
|Boston, Massachusetts, United States, 02215|
|Principal Investigator:||Michael W Donnino, MD||Beth Israel Deaconess Medical Center|